Actuarial Week in Review: October 26 to October 30, 2026

From tracking this week's developments, the final week of October delivered an unusually clear picture of an industry pulling in two directions at once. Property and reinsurance markets are flush with capital and softening quickly, while casualty lines, Medicare Advantage, and the still-unpriced world of AI liability are all throwing off warning signals. For actuaries, that split matters: the easy money in underwriting results is coming from the lines where rate adequacy is eroding fastest, and the hard problems are accumulating in the lines where loss trends are least settled.

Soft Property Rates Meet Hard Casualty Trends

The headline market data this week was not subtle. Commercial P&C rates fell for the ninth consecutive quarter, with property softening further (as reported by Risk & Insurance), and global commercial rates dropped 5% in the third quarter with only tentative signs of stabilization (according to Carrier Management). Specialty lines are giving back ground even faster: Intelligent Insurer reports that roughly 65% of the rate strengthening gains from the recent hard market have now been eroded. The energy market offers a microcosm, with property softening while casualty pricing merely flattens (Risk & Insurance).

The driver is straightforward. Catastrophe losses stayed below average through the first nine months of 2026 (Risk & Insurance), cat bond issuance is running at a record pace, and alternative capital is finding wider acceptance (Business Insurance). Florida's Hurricane Catastrophe Fund is projected to sit near $13 billion at year-end (Intelligent Insurer), and Universal's reinsurance bill fell as the Florida market turns a corner (Insurance Business). Munich Re raised its 2026 profit guidance to €6.6 billion on strong preliminary third quarter results (Insurtech Insights), explicitly ahead of what it expects to be a soft January renewal.

Third quarter earnings reflected the same dynamic. Chubb posted a record $5.79 billion in P&C underwriting income for the first nine months (Insurtech Insights), Arch reported a $1 billion profit even as reinsurance premiums declined (Coverager), and The Hartford's net income rose 23% while core earnings slipped (Business Insurance). RenaissanceRe's $161 million loss (Coverager) was the notable exception.

Against this backdrop, the casualty story deserves more attention than it is getting. AM Best attributed a surge in commercial auto liability claims to social inflation (Claims Journal), and Risk & Insurance documented the added pressure on commercial auto and general liability results. The actuarial implication is a classic reserving trap: strong calendar-year results driven by benign property experience can mask accident-year deterioration in long-tail casualty. Reserve adequacy reviews this cycle should isolate severity trend assumptions in auto liability and umbrella from the broader book, and pricing actuaries should resist letting portfolio-level profitability justify casualty rate concessions. The super El Niño now forming, flagged by money managers as leaving "nowhere to hide" (Claims Journal), is also a reminder that below-average cat experience is a draw from a distribution, not a trend.

AI Moves From Pilot to Platform, and Into the Liability Column

The week's largest transaction was Guidewire's agreement to acquire hyperexponential, the UK pricing and underwriting software firm, for up to $2.1 billion (Life Insurance International, Insurtech Insights). Guidewire's Rosenbaum positioned agentic underwriting at the center of the deal (Insurance Innovation Reporter), and the company simultaneously extended its core platform for agentic insurance. For pricing actuaries, this is a signal that the tooling layer where actuarial models live is consolidating around core-system vendors. Model governance frameworks written for spreadsheet-era rating engines will need updating when pricing logic is embedded in agent workflows that touch quote, bind, and renewal.

Distribution is changing just as fast. A-MAX, esure, and Sure all launched quoting through ChatGPT this week (Coverager), and Verisk expanded its content into Amazon Quick, Microsoft Copilot, and Claude (Insurtech Insights). Digital Insurance's analysis that AI agents "shop nonstop" and could trigger an auto rate-shopping rebound is the piece pricing actuaries should read twice. Personal lines retention assumptions, and the lifetime value models built on them, rest on consumer inertia. If an agent re-shops every renewal automatically, renewal elasticity shifts, price optimization strategies that lean on inertia become both less effective and more exposed to regulatory scrutiny, and persistency assumptions in embedded value and plan projections need stress testing.

A pattern emerging across several of this week's stories is that the industry is now openly uncomfortable with AI as an insured peril. Anthropic warned that AI-related losses could exceed insurance industry capacity (Business Insurance). Chubb CEO Evan Greenberg said the industry has to "put arms around" AI liability (Carrier Management), and CRC Specialty's CEO suggested it may take real losses before AI insurance sells (Insurance Business). Meanwhile Moody's observed that insurers keep raising AI budgets before seeing returns (Digital Insurance). For actuaries, AI liability is the kind of emerging risk where exposure is accumulating silently inside existing general liability, E&O, and cyber policies through silent coverage. The NAIC's finding that cyber direct premiums are up but the majority of policies remain endorsements rather than standalone (Carrier Management, Insurance Journal) is the same problem in a different wrapper, and the PHP security flaw analysis in Insurance Journal highlights how a single software dependency can aggregate across a book. Exposure management teams should be asking the same aggregation questions of AI model dependencies that they now ask of cloud providers.

Medicare Advantage Litigation and the Coverage Contraction

Health actuaries had a difficult week. Both CVS and Centene sued CMS over 2027 Medicare Advantage star ratings, with CVS seeking to prevent what it characterized as a $2 billion hit (Healthcare Dive). Star ratings drive quality bonus payments and rebate dollars, which flow directly into bid pricing and benefit design. A two-year lag between measurement and payment means that a rating outcome now determines 2027 bid economics that were submitted months ago, and litigation adds timing uncertainty on top of financial uncertainty. Actuaries certifying MA bids and reserving for risk-sharing arrangements should be building explicit scenarios around rating reversals rather than treating the published ratings as fixed inputs.

The broader market is contracting. KFF reports more than 4 million Medicare beneficiaries will have their MA or stand-alone Part D plan terminated at the end of 2026, a structural retreat from unprofitable counties and products. Centene posted a $71 million third quarter loss on $50.6 billion of revenue (Fierce Healthcare) even while raising guidance as Medicare gains offset what Insurance Business called an ACA enrollment collapse. The Commonwealth Fund put the 2026 uninsured rate at 11.2% (Fierce Healthcare), Democratic senators are probing insurers' role in cancellation of ACA coverage for 760,000 people, and CMS proposed heightened verification standards for ACA financial assistance (Healthcare Dive). States are racing to implement H.R. 1 Medicaid changes in what Fierce Healthcare described as "not a normal build."

The actuarial consequence is morbidity shift. As enrollment falls, the remaining risk pool skews sicker, and the standard risk adjustment mechanisms calibrate on the prior population. Rate filings for 2027 and 2028 will need to defend trend and morbidity assumptions that depart materially from historical experience, and the credibility of recent data is itself in question. HCA's warning about persistent payer mix deterioration (Fierce Healthcare) is the provider-side echo of the same problem.

Longevity, Mortality Improvement, and the Pension Risk Transfer Pipeline

The Society of Actuaries released the RPEC 2026 Mortality Improvement Update alongside new research on the mortality impact of sedentary behavior and physical activity (SOA Research). The RPEC update is the annual anchor for pension and annuity valuation, and practitioners should expect auditors and regulators to ask whether and how it has been reflected in year-end assumptions. The sedentary behavior work is a useful reminder that mortality improvement is not uniform across socioeconomic or behavioral segments, which matters for both PRT pricing and life underwriting.

On the demand side, LIMRA reported nearly $3 billion in US pension risk transfer sales for the second quarter, and PLANSPONSOR published a fiduciary framework for evaluating insurer durability in PRT transactions, a direct response to ongoing litigation over annuity provider selection. Capital is arriving to meet that demand: Symetra and TIAA launched Mariner Re with $750 million of backing (Intelligent Insurer, Coverager). Goldman Sachs research found insurers increasingly bullish on in-plan annuity adoption (PLANSPONSOR, Plan Adviser), while multiple surveys scored Americans poorly on longevity readiness (InvestmentNews, 401k Specialist). The PBGC also updated its 2027 maximum guarantee tables and premiums (PLANSPONSOR). Internationally, Challenger rejected Daiichi Life's A$7.9 billion bid and Prudential Financial agreed to divest its Brazil and Mexico businesses for more than $4 billion (Life Insurance International), both signs that life and retirement capital is being reallocated toward markets where longevity risk can be priced and hedged.

For retirement actuaries, the combination is notable: improving longevity assumptions, heavy PRT volume, new reinsurance capacity, and heightened fiduciary scrutiny of insurer solvency all land at once. Capital modeling for annuity writers should explicitly address the concentration risk that arises when a small number of reinsurers absorb a large share of transferred longevity exposure.

Investment Scrutiny and the Rate Path

Two quieter items deserve mention. Risk.net reported that an NAIC proposal hints at wider scrutiny of insurer investments, continuing the regulatory focus on private credit and structured assets that has shaped the last several years. And while the Fed was expected to hold this week, InvestmentNews noted that December hike odds exceeded 70%. A rising rate environment improves reinvestment yields but reintroduces interest rate risk on surrender-sensitive liabilities and pressures the market value of the longer-duration portfolios backing PRT business. ALM teams should refresh their disintermediation scenarios accordingly.

Looking Ahead

Three things to watch next week. First, ACA open enrollment begins November 1, and early enrollment data will be the first real test of how verification changes and reduced subsidies affect the risk pool. Second, the Department of Labor's PBM transparency rule, previewed by Plan Adviser, could reshape how plan sponsors and their actuaries evaluate pharmacy spend. Third, the remaining third quarter earnings and early January renewal commentary will show whether reinsurers intend to defend casualty pricing while property rates fall, or whether the whole market simply follows the capital.